miR‐200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2

Oral submucous fibrosis (OSF) is a progressive scarring disease. MicroRNA‐200b (miR‐200b) has been reported as a tumour suppressor, but its role in the precancerous OSF remains unknown. In this study, we investigated the impact of miR‐200b on myofibroblastic differentiation activity. Arecoline is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yi‐Wen, Yu, Cheng‐Chia, Hsieh, Pei‐Ling, Chang, Yu‐Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111815/
https://www.ncbi.nlm.nih.gov/pubmed/29893466
http://dx.doi.org/10.1111/jcmm.13690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111815/
https://www.ncbi.nlm.nih.gov/pubmed/29893466
http://dx.doi.org/10.1111/jcmm.13690

Ejemplares similares